vs
HERITAGE FINANCIAL CORP（HFWA）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是HERITAGE FINANCIAL CORP的1.1倍（$75.5M vs $66.3M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 16.3%），HERITAGE FINANCIAL CORP自由现金流更多（$85.7M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 16.8%）
总部位于美国华盛顿州的区域性金融控股公司，面向太平洋西北地区的当地社群提供服务，核心业务涵盖商业与零售银行服务，包含存款产品、中小企业贷款、住房抵押贷款、个人信贷及财富管理解决方案，核心客群为中小微企业及个人客户。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
HFWA vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.1倍
$66.3M
营收增速更快
PBYI
高出11.4%
16.3%
自由现金流更多
HFWA
多$71.3M
$14.4M
两年增速更快
PBYI
近两年复合增速
16.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $66.3M | $75.5M |
| 净利润 | $22.2M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 38.7% | 22.7% |
| 净利率 | 33.5% | — |
| 营收同比 | 16.3% | 27.7% |
| 净利润同比 | 86.4% | — |
| 每股收益（稀释后） | $0.65 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HFWAPBYI
| Q4 25 | $66.3M | $75.5M | ||
| Q3 25 | $65.7M | $54.5M | ||
| Q2 25 | $56.5M | $52.4M | ||
| Q1 25 | $57.6M | $46.0M | ||
| Q4 24 | $57.1M | $59.1M | ||
| Q3 24 | $54.8M | $80.5M | ||
| Q2 24 | $56.4M | $47.1M | ||
| Q1 24 | $48.6M | $43.8M |
净利润HFWAPBYI
| Q4 25 | $22.2M | — | ||
| Q3 25 | $19.2M | $8.8M | ||
| Q2 25 | $12.2M | $5.9M | ||
| Q1 25 | $13.9M | $3.0M | ||
| Q4 24 | $11.9M | — | ||
| Q3 24 | $11.4M | $20.3M | ||
| Q2 24 | $14.2M | $-4.5M | ||
| Q1 24 | $5.7M | $-4.8M |
毛利率HFWAPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率HFWAPBYI
| Q4 25 | 38.7% | 22.7% | ||
| Q3 25 | 34.0% | 17.6% | ||
| Q2 25 | 25.6% | 12.7% | ||
| Q1 25 | 28.1% | 8.7% | ||
| Q4 24 | 28.6% | 22.6% | ||
| Q3 24 | 23.8% | 27.4% | ||
| Q2 24 | 28.4% | -4.6% | ||
| Q1 24 | 14.1% | -5.3% |
净利率HFWAPBYI
| Q4 25 | 33.5% | — | ||
| Q3 25 | 29.2% | 16.2% | ||
| Q2 25 | 21.6% | 11.2% | ||
| Q1 25 | 24.2% | 6.5% | ||
| Q4 24 | 20.9% | — | ||
| Q3 24 | 20.8% | 25.2% | ||
| Q2 24 | 25.1% | -9.6% | ||
| Q1 24 | 11.8% | -11.0% |
每股收益（稀释后）HFWAPBYI
| Q4 25 | $0.65 | $0.26 | ||
| Q3 25 | $0.55 | $0.17 | ||
| Q2 25 | $0.36 | $0.12 | ||
| Q1 25 | $0.40 | $0.06 | ||
| Q4 24 | $0.34 | $0.40 | ||
| Q3 24 | $0.33 | $0.41 | ||
| Q2 24 | $0.41 | $-0.09 | ||
| Q1 24 | $0.16 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $233.1M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $921.5M | $130.3M |
| 总资产 | $7.0B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资HFWAPBYI
| Q4 25 | $233.1M | $97.5M | ||
| Q3 25 | $245.5M | $94.4M | ||
| Q2 25 | $254.1M | $96.0M | ||
| Q1 25 | $248.7M | $93.2M | ||
| Q4 24 | $117.1M | $101.0M | ||
| Q3 24 | $175.6M | $96.7M | ||
| Q2 24 | $113.8M | $96.8M | ||
| Q1 24 | $189.6M | $107.2M |
总债务HFWAPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益HFWAPBYI
| Q4 25 | $921.5M | $130.3M | ||
| Q3 25 | $904.1M | $115.3M | ||
| Q2 25 | $888.2M | $104.7M | ||
| Q1 25 | $881.5M | $97.1M | ||
| Q4 24 | $863.5M | $92.1M | ||
| Q3 24 | $874.5M | $71.1M | ||
| Q2 24 | $850.5M | $48.5M | ||
| Q1 24 | $847.6M | $51.0M |
总资产HFWAPBYI
| Q4 25 | $7.0B | $216.3M | ||
| Q3 25 | $7.0B | $202.9M | ||
| Q2 25 | $7.1B | $194.9M | ||
| Q1 25 | $7.1B | $196.2M | ||
| Q4 24 | $7.1B | $213.3M | ||
| Q3 24 | $7.2B | $220.7M | ||
| Q2 24 | $7.1B | $205.0M | ||
| Q1 24 | $7.1B | $214.1M |
负债/权益比HFWAPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $94.8M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $85.7M | $14.4M |
| 自由现金流率自由现金流/营收 | 129.1% | 19.1% |
| 资本支出强度资本支出/营收 | 13.8% | 0.0% |
| 现金转化率经营现金流/净利润 | 4.26× | — |
| 过去12个月自由现金流最近4个季度 | $149.0M | $41.7M |
8季度趋势，按日历期对齐
经营现金流HFWAPBYI
| Q4 25 | $94.8M | $14.4M | ||
| Q3 25 | $25.1M | $9.7M | ||
| Q2 25 | $22.5M | $14.1M | ||
| Q1 25 | $19.3M | $3.6M | ||
| Q4 24 | $64.5M | $15.6M | ||
| Q3 24 | $24.2M | $11.0M | ||
| Q2 24 | $6.8M | $1.0M | ||
| Q1 24 | $12.9M | $11.2M |
自由现金流HFWAPBYI
| Q4 25 | $85.7M | $14.4M | ||
| Q3 25 | $24.4M | $9.7M | ||
| Q2 25 | $20.9M | $14.1M | ||
| Q1 25 | $18.1M | $3.6M | ||
| Q4 24 | $61.0M | $15.6M | ||
| Q3 24 | $23.2M | $11.0M | ||
| Q2 24 | $6.0M | $1.0M | ||
| Q1 24 | $12.0M | — |
自由现金流率HFWAPBYI
| Q4 25 | 129.1% | 19.1% | ||
| Q3 25 | 37.1% | 17.7% | ||
| Q2 25 | 37.0% | 26.8% | ||
| Q1 25 | 31.4% | 7.7% | ||
| Q4 24 | 107.0% | 26.4% | ||
| Q3 24 | 42.4% | 13.7% | ||
| Q2 24 | 10.6% | 2.1% | ||
| Q1 24 | 24.7% | — |
资本支出强度HFWAPBYI
| Q4 25 | 13.8% | 0.0% | ||
| Q3 25 | 1.0% | 0.0% | ||
| Q2 25 | 2.8% | 0.0% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 6.1% | 0.0% | ||
| Q3 24 | 1.7% | 0.0% | ||
| Q2 24 | 1.5% | 0.0% | ||
| Q1 24 | 1.8% | 0.0% |
现金转化率HFWAPBYI
| Q4 25 | 4.26× | — | ||
| Q3 25 | 1.31× | 1.10× | ||
| Q2 25 | 1.84× | 2.41× | ||
| Q1 25 | 1.38× | 1.21× | ||
| Q4 24 | 5.41× | — | ||
| Q3 24 | 2.12× | 0.54× | ||
| Q2 24 | 0.48× | — | ||
| Q1 24 | 2.24× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
